Instituto de Investigación Sanitaria Hospital 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2024

  1. CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts

    OncoImmunology, Vol. 13, Núm. 1

  2. Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates

    Toxicology and Applied Pharmacology, Vol. 487

2023

  1. A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response

    OncoImmunology, Vol. 12, Núm. 1